Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
1933results about How to "Avoid pain" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
InactiveUS20060004306A1Big advantageSufficient amountElectrotherapyChiropractic devicesElectromagnetic radiationBiomedical engineering
Methods of treatment of tissue with electromagnetic radiation (EMR) to produce lattices of EMR-treated islets in the tissue are disclosed. Also disclosed are devices and systems for producing lattices of EMR-treated islets in tissue, and cosmetic and medical applications of such devices and systems.
Owner:PALOMAR MEDICAL TECH
Systems and methods for posterior dynamic stabilization of the spine
InactiveUS20080097441A1Reduces and eliminates facet painLiquidityInternal osteosythesisJoint implantsSpinal columnInterconnection
Systems and devices for dynamically stabilizing the spine are provided. The systems include a superior component for attachment to a superior vertebra of a spinal motion segment and an inferior component for attachment to an inferior vertebral of a spinal motion segment. The interconnection between the two components enables the spinal motion segment to move in a manner that mimics the natural motion of the spinal motion segment while substantially offloading the facet joints of the spine. Methods are also provided for stabilizing the spine and for implanting the subject systems.
Owner:EXACTECH INC
Elastic stabilization system for vertebral columns
ActiveUS7125410B2Simple and safe implantation techniqueAvoid painSuture equipmentsInternal osteosythesisSpinal implantPedicle screw
A vertebral column implant for the elastic stabilization of motion segments (1, 2) comprising an elastically bendable connecting element (5) which can be passed through the seats (4) of a number of pedicle screws (3) having offset seat axes (6a, 6b, 6c) and be anchored. The connecting element is bendable elastically about every axis of its cross-section in such a way that the connecting element can be passed through, or inserted in, the seats of the screwheads, one behind the other, even when the seats are not situated on one and the same axis. The connecting element and the seat in the screwhead each have wholly, or in part, a structured surface, in such a way that the structured surface of the seat engages the structured surface of the connecting element, and shifting can be prevented in assembled condition.
Owner:SPINELAB AG
Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
InactiveUS20060020309A1Sufficient amountReduce riskElectrotherapySurgical instrument detailsElectromagnetic radiationBiomedical engineering
Owner:PALOMAR MEDICAL TECH
Devices and methods for accessing and analyzing physiological fluid
InactiveUS7343188B2Convenient angleReduce painSensorsBiological testingLiquid glucosePhysiological fluid
Owner:LIFESCAN IP HLDG LLC
Clostridial toxin derivatives able to modify peripheral sensory afferent functions
InactiveUS6395513B1Pain reliefReduce and preferably prevent transmissionNervous disorderPeptide/protein ingredientsClostridial toxinProjection neuron
The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neuron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.
Owner:HEALTH PROTECTION AGENCY +1
Topical compositions and methods for treating pain
InactiveUS6638981B2Avoid painComposition is stableBiocideNervous disorderNR1 NMDA receptorPreventing pain
Owner:EPICEPT CORP
Devices and Methods for Accessing and Analyzing Physiological Fluid
InactiveUS20080009768A1Irritation and pain be avoidRapidly and accurately detect occurrenceSensorsBiological testingSkin penetrationSubject specific
Systems, devices and methods for determining the concentration of physiological fluid analytes are provided. The subject systems have a plurality of biosensor devices present on a disposable cartridge. Each biosensor device includes a biosensor and a skin penetration means. In practicing the subject methods, a movement means of the device is used to move each biosensor device in a first direction that provides for penetration of the skin-piercing means into a skin layer followed by movement of the biosensor in a second direction that provides for removal of the skin-piercing means from the skin layer, where this movement profile provides for physiological fluid access and analyte concentration determination by the analyte sensor means. The subject systems, devices and methods for using the same find use in determining the concentration of a variety of different physiological fluid analytes, and are particularly suited for use in detection of physiological fluid glucose concentration.
Owner:LIFESCAN INC
Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
InactiveUS7052702B1Pain reliefReduce and preferably prevent transmissionNervous disorderBacteriaGalactose binding lectinProtein translocation
A class of novel agents that are able to modify nociceptive afferent function is provided. The agents may inhibit the release of neurotransmitters from discrete populations of neurones and thereby reduce or preferably prevent the transmission of afferent pain signals from peripheral to central pain fibers. They comprise a galactose-binding lectin linked to a derivative of a clostridial neurotoxin. The derivative of the clostridial neurotoxin comprises the L-chain, or a fragment thereof, which includes the active proteolytic enzyme domain of the light (L) chain, linked to a molecule or domain with membrane translocating activity. The agents may be used in or as pharmaceuticals for the treatment of pain, particularly chronic pain.
Owner:HEALTH PROTECTION AGENCY +1
Robot assisted bone setting operation medical system with lock marrow internal nail
InactiveCN1561923AAchieve therapeutic effectImprove general performanceInternal osteosythesisDiagnosticsDistance HealingSimulation
A robot aided surgical system for the bone setting operation with the locking intramedullary nail is composed of multifunctional automatic operation bed, robot, bone setting regulator on said robot, bone fixing mechanism, high-accuracy full-automatic X-ray machine with C-shaped arm, navigation robot, robot controller, master hand control station, and slave hand control station.
Owner:HARBIN INST OF TECH
Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists
InactiveUS7226910B2Good for healthImprove the lubrication effectBiocidePeptide/protein ingredientsObstetricsActive agent
Owner:VIVUS
Biocompatible hemostatic, antiblocking, healing-promoting and surgical wound-closing modified starch material
InactiveCN101485897AMaterials that promote healingPromote repairOrganic active ingredientsSurgical adhesivesTissue fluidBandage
The invention relates to a modified starch material for biocompatible hemostasis, biocompatible anti-adhesion, tissue healing promotion, absorbable surgery sealing and tissue adhesion. The invention applies biocompatible modified starch to animal tissues, wherein the modified starch material has the molecular weight of more than 15,000 daltons, and the particle diameter of between 1 and 1,000 mu m. The modified starch hemostatic material has stypticity, reduces hemorrhage, blood oozing and tissue fluid oozing of wounds, maintains relative moistening or drying of wound surfaces or the wounds, inhibits bacterium growth and inflammation reaction, and contributes to locally diminish inflammation of the wounds and relieve pain of patients. Moreover, the modified starch material can wash local parts after operation is over and remove redundant modified starch which does not participate in hemostasis, and can easily remove haemostatic under the condition of debridement treatment after self-help and first-aid treatment of war wounds; and hemostatic materials with a small amount of modified starch can be absorbed by the body, so that the pain of tearing of gauzes and bandages on people is avoided.
Owner:BEIJING UNIVERSAL LIKANG TECH CO LTD
Non-invasive characterization of a physiological parameter
InactiveUS20100324398A1Insensitive to fluctuating patientInsensitive to environment conditionSensorsBlood characterising devicesData setPatient data
The present invention provides a method and device for characterizing a physiological parameter. The method, in one application, uses one or more non-invasive sensors to collect patient data, and may also collect data on environmental conditions. At least some of the patient data has a direct relationship with the physiological parameter, that is, a change in the physiological parameter is reflected in the data set, although the magnitude of the physiological parameter may masked by noise, interference, or other environmental or patient influences. The direct patient data preferably has a generally linear relationship with the physiological parameter, and if not, the patient data is linearized according to an algorithm, table, or other adjustment process. These linearizing processes may be predefined, and may adaptively learn or adjust. A blind signal source process is applied to the linearized data to generate separated signals, and the signal associated with the physiological parameter is identified. The identified signal is scaled or further processed, and the characterization result is presented. Although the method and device are described for use with a human, they may be advantageously used on animals.
Owner:TZYY PING JUNG
Folding chair
InactiveUS6899383B2Give a user seating comfort and stabilityAvoid painFoldable chairBenchesEngineeringBack rests
Disclosed is a folding chair comprising a frame and a seat sheet, which has means for protecting a user's vertebral column and means for expanding the seat to improve its seating comfort and stability. The expanding means are connected to both sides of the seat, and the protecting means is coupled at its opposite ends to armrests, upper portions of frame elements or the expanding means. The expanding means are hanged on projections formed by bending upper portions of the front frame elements. The protecting means is held at a certain height on a back rest of the chair but being allowed to be laterally moved by holding means, thereby enabling length of the protecting means to be adjusted. The folding chair may have one or more means for protecting a user's vertebral column.
Owner:HWANG JOO HWAN
Methods for treatment of headaches by administration of oxytocin
InactiveUS20070054843A1Reduction of pain ratingReduce probabilityOrganic active ingredientsNervous disorderHeadache DisordersTrigeminal neuralgia
The present invention relates to methods for the treatment of headache and headache disorders. The methods comprise administration of an oxytocin peptide for the treatment of primary and secondary headaches or trigeminal neuralgia.
Owner:THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV +2
Electronic apparatus including removable dust catcher
InactiveUS20070131383A1Effective radiationAvoid painCombination devicesDispersed particle filtrationEngineeringHeat sink
A fan is enclosed in the enclosure of an electronic apparatus. The fan discharges air out of a ventilation opening of the fan itself. Heat radiating fins are located in an air passage extending from the ventilation opening. A dust catcher is removably mounted in an opening of the enclosure from the outside of the enclosure. The dust catcher is located in the air passage between the heat radiating fins and the ventilation opening. The dust catcher serves to catch the dust in the air passage. The dust catcher is removed from the enclosure along with the dust. The dust is thus reliably cleared from the air passage. The dust catcher can then be cleaned. The cleaned dust catcher can again be set in the opening of the enclosure. Airflow of a sufficient amount is in this manner always kept in the air passage.
Owner:FUJITSU CLIENT COMPUTING LTD
Systems and methods for posterior dynamic stabilization of the spine
InactiveUS8025680B2LiquidityReduces and eliminates painInternal osteosythesisJoint implantsSpinal columnInterconnection
Systems and devices for dynamically stabilizing the spine are provided. The systems include a superior component for attachment to a superior vertebra of a spinal motion segment and an inferior component for attachment to an inferior vertebral of a spinal motion segment. The interconnection between the two components enables the spinal motion segment to move in a manner that mimics the natural motion of the spinal motion segment while substantially offloading the facet joints of the spine. Methods are also provided for stabilizing the spine and for implanting the subject systems.
Owner:EXACTECH INC
Pain management using cryogenic remodeling
ActiveUS20090248001A1Avoid ablationInduce apoptosis of the nerveSurgical instruments for coolingTherapeutic coolingMuscle contractionPain management
Medical devices, systems, and methods for pain management and other applications may apply cooling with at least one probe inserted through an exposed skin surface of skin. The cooling may remodel one or more target tissues so as to effect a desired change in composition of the target tissue and / or a change in its behavior, often to interfere with transmission of pain signals along sensory nerves. Alternative embodiments may interfere with the function of motor nerves, the function of contractile muscles, and / or some other tissue included in the contractile function chain so as to inhibit muscle contraction and thereby alleviate associated pain. In some embodiments, other sources of pain such as components of the spine (optionally including herniated disks) may be treated.
Owner:PACIRA CRYOTECH INC
Therapeutic device and system
InactiveUS7396345B2Avoid discomfortAvoid painBlood stagnation preventionStentsTherapeutic DevicesBiomedical engineering
Therapeutic devices that provide support or pressure to tissue. Devices contain a material that is capable of being contracted from its relaxed state to an evacuated state. The material applies pressure to the tissue of a patient when the material is in its relaxed state. Reduction of pressure by application of a vacuum results in a contracted state of the device, so that the device can be applied or delivered to a patient. Release of vacuum results in a return to the relaxed state, thus providing a maximum desirable pressure to tissue and avoiding the possibility of over-pressure which can result in tissue damage or necrosis.
Owner:EMBRO CORP
Topical compositions and methods for treating pain
InactiveUS20030082214A1Treating and preventing painAvoid painBiocideNervous disorderPreventing painNR1 NMDA receptor
Topical compositions and methods for treating pain. The invention provides oil-in-water emulsions comprising an antidepressant; an NMDA-receptor antagonists; a lipophilic component; water; and a surfactant. The compositions induce a local-anesthetic effect when topically administered to intact skin thereby treating or preventing pain, for example, neuropathic pain.
Owner:EPICEPT CORP
As-needed administration of an androgenic agent to enhance female desire and responsiveness
InactiveUS20050070516A1Improving tissue healthImprove responsivenessElcosanoid active ingredientsNanomedicineOral medicationUrethra
A method is provided for enhancing a female individual's sexual desire and responsiveness. The method involves administration of a pharmaceutical formulation containing an effective amount of an androgenic agent, wherein administration is on an as-needed basis rather than involving chronic pharmacotherapy. Local delivery may be accomplished via administration to the vagina, vulvar area or urethra of the individual, although oral administration is preferred for those androgenic agents that are orally active. Formulations and kits for carrying out the method are provided as well.
Owner:VIVUS
Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain
InactiveUS20060276414A1Increasing cell proliferationHigh affinityOrganic active ingredientsBiocideGynecologyPresent method
The present invention relates to a method of treating or preventing musculoskeletal pain in a mammal receiving administration of an estrogen. suppressant selected from the group consisting of aromatase inhibitors, GnRH analogues, cyclo-oxy-genase 2 (COX-2) inhibitors, 17β-hydroxysteroid dehydrogenase type 1 inhibitors, progestogens, anti-estrogens and combinations thereof, said method comprising the administration of an effective amount of an estrogenic component, wherein the estrogenic component is selected from the group consisting of: substances represented by the following formula (1) in which formula R1, R2, R3, R4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; precursors capable of liberating a substance according to the aforementioned formula when used in the present method; and mixtures of one or more of the aforementioned substances and / or precursors.
Owner:COELINGH BENNINK HERMAN JAN TIJMEN +1
Clostridial toxin derivatives able to modify peripheral sensory afferent functions
InactiveUS20030049264A1Pain reliefReduce and preferably prevent transmissionNervous disorderHydrolasesClostridial toxinMedicine
The invention relates to an agent specific for peripheral sensory afferents. The agent may inhibit the transmission of signals between a primary sensory afferent and a projection neutron by controlling the release of at least one neurotransmitter or neuromodulator from the primary sensory afferent. The agent may be used in or as a pharmaceutical for the treatment of pain, particularly chronic pain.
Owner:HEALTH PROTECTION AGENCY +1
Portable binder with a rotating frame
InactiveUS20100327030A1Brought by users conveniently when theyEasy to useTravelling sacksTravelling carriersRotational axisEngineering
The present invention relates to a portable binder with a rotating frame, comprising a pedestal and a rotating frame, wherein the pedestal has a base and on both sides of the base, there is a lacing hole to be reeved by a binding tape, which can be used by tightening it around arms. An axle hole penetrates through the base to combine a coaxial connection shaft, and on the base, a supporting plate is established concavely on both sides to cover a proposed electronic device, while an axial part is established to interconnect the coaxial connection shaft on the supporting plate, and on the axial part, there is a rotation shaft that can be coaxially connected with the coaxial connection shaft. When the binding tape reeving the base is fastened around users' arms, the body of the rotating frame can be utilized to fix the electronic device, thus achieving the effect of making the electronic device portable when users go out. Besides, the design of adjusting the visual angle by using the rotating frame makes it convenient to use the portable binder disclosed in the present invention.
Owner:YANG SHANG WEN
Biocompatibility modified starch sponges
ActiveCN101455857AFlexibleActive bleeding is easily controlledAbsorbent padsBandagesFreeze-dryingBiocompatibility Testing
The invention relates to biocompatible modified starch sponge and use of the biocompatible modified starch sponge as a hemostatic material, an anti-adhesion material, a material for promoting tissue healing, a surgical sealant or a wound tissue adhesive. Modified starch is one or a combination of more than one among pre-gelatinized starch, acid modified starch, dextrin, oxidized starch, esterified starch, etherified starch, crosslinked starch, grafted starch and composite modified starch. The sponge is prepared by vacuum freeze drying of the modified starch and other biocompatible hemostatic material, coagulant, plasticizer and so on. The biocompatible modified starch sponge has the advantages that the biocompatible modified starch sponge has flexible form and good biocompatibility, can be directly acted on bloody wound surfaces, avoids the conditions of hypersusceptibility, infection and difficult healing of wounds caused by adoption of hemostatic materials such as animal source / human source collagens, obviously improves the water absorption speed, has larger viscosity, forms a zymoplastic mixture which has good adhesion, calks broken tissues and blood vessels, and is used for hemostasis of active hemorrhage.
Owner:BEIJING UNIVERSAL LIKANG TECH CO LTD
Back traction and muscle stretching bench
InactiveUS20050181917A1Decrease static pressureBeneficial in treatmentChiropractic devicesStiltsEngineeringThigh musculature
Owner:DAYAL SOORYA
Laser Device and Method of Use
InactiveUS20150057648A1Reduce power densityReduce temperature peaksSurgical instrument detailsCatheterSide effectRadiology
It is an object and advantage of this invention to provide an improved device and method that uses targeted laser wavelength to treat a diseased vessel. An advantage of this invention is targeted ablation of diseased vessels without harming non-target tissue. This new technique allows for a controlled ablation, may not require injection of tumescent anesthesia prior to treatment and may decrease unwanted or unintended side effects.
Owner:ANGIODYNAMICS INC
Modified starch absorbable hemostasia material and preparation method thereof
ActiveCN101361986AHigh viscosityImprove water absorption speedSurgical adhesivesPharmaceutical delivery mechanismWound healingBiomedical engineering
Owner:BEIJING UNIVERSAL LIKANG TECH CO LTD
Near-infrared spectrum imaging system and near-infrared spectrum imaging method for diagnosis of depth and area of burn skin necrosis
ActiveCN103815875AFavorable guidanceAvoid painDiagnostics using spectroscopyOptical sensorsTissue proteinBurned skin
The invention provides a near-infrared spectrum imaging system for diagnosis of depth and area of burn skin necrosis. The near-infrared spectrum imaging system comprises a spectrum imager and a computer-control system. The spectrum imager acquires 1100-2500nm waveband spectral signals of burn skin necrosis tissue of a target area, the spectral signals are subjected to image analyzing and processing through the computer-control system, the depth and area of burn of the target area can be acquired through spectral matching recognition upon a spectral reflectance curve corresponding to each image element in spectral images and a standard spectral reflectance curve in a burn skin necrosis spectral database in a data module and are synthesized into three-dimensional image display of the target area. By the near-infrared spectrum imaging system, the spatial structure of skin changed due to tissue protein denaturation before and after the skin burn can be specified, so that micron-level information about boundaries of normal skin tissue and necrotic tissue and the depth of burn skin necrosis can be provided visually, and clinical diagnosis, treatment and prognosis judgment can be supportively facilitated.
Owner:ZHEJIANG DEPUSI MEDICAL TECH CO LTD
Method and apparatus for monitoring external physical parameters having an influence on the onset or progression of a medical condition
InactiveUS20090209830A1ConnectionReduce poolingElectrotherapySurgeryMeasurement devicePatient compliance
A patient compliance monitor (10) for monitoring compliance of a patient to a treatment regime for treatment of a medical condition, the patient compliance monitor comprising measurement means (12) for measuring an external physical parameter acting on a limb of the said patient, the external physical parameter having an influence on the medical condition experienced by said limb; recording means (14) for recording over a period of time data representative of the physical parameter; and comparative means for comparing the recorded data with data indicative of the treatment regime to determine patient compliance to the treatment regime.
Owner:WOUND SOLUTIONS LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com